Skip to content

Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

VeraCode Genotyping Test for Factor V and Factor II on the BeadXpress System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00959504
Enrollment
275
Registered
2009-08-14
Start date
2009-08-31
Completion date
2009-09-30
Last updated
2011-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection and Genotyping of Factor V and Factor II Point Mutations

Brief summary

As an external validation test of the performance of the VeraCode Genotyping Test for Factor V and Factor II on the BeadXpress System, clinical trials will be conducted at three sites. This study will assess genotyping accuracy as compared to bidirectional sequencing and genotyping reproducibility across variables such as user, day, and site.

Interventions

None listed

Sponsors

Illumina, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patient samples will be leftover EDTA-anticoagulated whole blood from patients referred for Factor V and/or Factor II testing.

Exclusion criteria

* There are no applicable

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026